Foot News and Research

RSS

Results of Phase 3 CRYSTAL study of mCRC patients announced

The retrospective CRYSTAL analysis was conducted as a result of an effort to increase the tissue ascertainment rate to determine the K-ras status of patients’ tumors. The analysis included extended patient follow up of nearly 1.5 years and doubled the tissue ascertainment rate from 45% to 89%. These data are an update from the overall survival results from CRYSTAL that were published in the April 2009 issue of the New England Journal of Medicine.

23 Sep 2009

Phase 2 trial results of Bayer's Nexavar in combination with capecitabine announced

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the full results from their first collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trial showing that Nexavar(R) (sorafenib) tablets in combination with the oral chemotherapeutic agent, capecitabine, significantly extended progression-free survival in patients with advanced breast cancer.

23 Sep 2009

KARL STORZ receives LEED Silver certification

KARL STORZ Endoscopy-America, Inc., a leader in diagnostic and operative minimally invasive endoscopic technology, is proud to announce that it has been awarded LEED® (Leadership in Energy and Environmental Design) Silver certification from the U.S. Green Building Council (USGBC) for the company’s North American Headquarters.

23 Sep 2009

Bioelectronics files for pre-marketing clearance for its ActiPatch® Therapy products

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced that it filed today with the U.S. Government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy products.

23 Sep 2009

ACR Image Metrix successfully completes two years, looks forward to increased business in third year

ACR Image Metrix™, an imaging contract research organization (CRO), exceeded its goals by initiating projects for over 30 pharmaceutical, biotechnology and medical device companies through its second full year of operation.

23 Sep 2009

Results of OASIS clinical trial reported by Cardiovascular Systems

Two-year follow-up of patients in the first-ever prospective, multi-center clinical trial evaluating a plaque removal product show promising results after treatment with the Diamondback 360® PAD System, a minimally invasive catheter system that removes hardened plaque to restore blood flow in arteries.

23 Sep 2009

Amnesty International report highlights maternal mortality 'emergency' in Sierra Leone

"One in eight women in Sierra Leone risks dying of pregnancy and childbirth complications exacerbated by a combination of poverty, discrimination, inequality and government mismanagement," according to an Amnesty International report, released Tuesday, Reuters AlertNet reports (Fominyen, 9/22).

23 Sep 2009

Alpha Orthotics announces launch of its Medial Mid-foot Brace in the U.S.

Splayfoot, also called "fallen arch" occurs when the arch of the foot collapses, with the entire sole of the foot coming into complete or near-complete contact with the ground. An estimated 20%-30% of Americans have this condition where the arch never develops, or collapses in one or both feet.

23 Sep 2009

'The Dr. Oz Show' and NAFC collaborate to hold an enormous free clinic

"The Dr. Oz Show," the new daily syndicated show hosted by cardiac surgeon and health expert Dr. Mehmet Oz, and the National Association of Free Clinics (NAFC), will hold an enormous free clinic at the Reliant Convention Center in Houston, Texas on Saturday September 26, 2009 to provide medical care to hundreds of people who have no form of basic health insurance.

22 Sep 2009

Beech Sandal Company supports breast cancer awareness program

Beech Sandal Company declares its commitment to raising awareness and funding for education, research and treatment for women's health issues by donating its popular, health-oriented Yoga Sandals(R) footwear and a portion of the company's sales to support a number of worthy causes.

22 Sep 2009

Bayer's regorafenib showed 50% stabilization rate in RCC patients

Bayer today announced results from a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase inhibitor, which demonstrated that treatment with regorafenib resulted in a 31 percent partial response rate and 50 percent stabilization rate in patients with metastatic renal cell carcinoma (RCC).

22 Sep 2009

Massachusetts College of Pharmacy and Health Sciences launches new academic center

Massachusetts College of Pharmacy and Health Sciences today officially opened a new 30,000 square foot, $10M academic center at 40 Foster St. in downtown Worcester. On hand at the event were Congressman Jim McGovern (D-MA), Worcester City Manager Michael O’Brien, Worcester Mayor Konstantina Lukes and MCPHS President Charles F. Monahan Jr.

21 Sep 2009

Dems divided over how to pay for reform

Democrats are divided over where the funds to pay for a health care overhaul will come from.

21 Sep 2009

Community events conducted by the Hospital at Craig Ranch

...

21 Sep 2009

Maximum Weight Limit is the new measure to calculate healthy weight

So, using SAS software and statistical procedures, he discovered a much simpler way of calculating a Maximum Weight Limit, which closely corresponds to weight recommendations listed on BMI charts. But, you don't need to calculate or know your BMI, nor do you need a chart or online calculator to figure out your Maximum Weight Limit. Fernandez will present his Maximum Weight Limit calculation at the Nevada Public Health Association Conference, 1:30 p.m., Sept. 22 at the University of Nevada, Reno's Joe Crowley Student Union, Room 423.

21 Sep 2009

KCI to conduct discussion on limb surgeries and amputations

Kinetic Concepts, Inc. (KCI) will sponsor a CME-accredited panel discussion, “The Role of NPWT in the Team Approach to Limb Salvage: Case Studies,” at the 3rd Annual Georgetown Diabetic Limb Salvage conference September 24-26.

19 Sep 2009

New ultra-thin adhesives introduced by Avery Dennison Specialty Tape Division

Avery Dennison Specialty Tape Division, an innovative leader in adhesive materials for the medical sector, introduced two new ultra-thin adhesives and a hydrocolloid and adhesive technology solution at MEDTEC China this week.

19 Sep 2009

80-unit patient housing facility for cancer patients and families

The SCCA House, an 80-unit patient housing facility for cancer patients and their families and caregivers, was dedicated today during ceremonies at its South Lake Union location. The facility is the second such "home away from home" building that is operated by the Seattle Cancer Care Alliance. Rooms are scheduled to be available to SCCA patients by the end of the month.

18 Sep 2009

Rising trend in youth sports-related injuries

Thirty million children and teens are busy gearing up for the fall athletic season. What they're not gearing up for is a sprained, strained or fractured ankle. However, US Consumer Product Safety Commission statistics reveal 3.5 million children and teens get hurt annually playing organized and/or school sports.

18 Sep 2009

SI-BONE's summit to develop clinical diagnostic process for SI Joint pathology identification

SI-BONE, Inc. a San Francisco Bay-area, medical device company, announced the first ever meeting of thought leading spine surgeons to review data and develop a clinical diagnostic process for identification of SI Joint pathology, a frequent cause of low back pain.

17 Sep 2009